BriaCell Therapeutics Corp. 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market information Our common shares and Warrants to purchase common shares trade on The Nasdaq Capital Market under the symbols “BCTX” and “BCTXW”, respectively, since February 24, 2021 and on the Toronto Stock Exchange (“TSX”) under the symbol “BCT” since December 31, 2021, and prior to that, on the TSX Venture Exchange from December 3, 2014. Number of Shareholders As of October 27, 2022, we have approximately 24 shareholders of record of our common shares. Dividend Policy Historically, we have not paid any dividends to the holders of shares of our common shares and we do not expect to pay any such dividends in the foreseeable future as we expect to retain our future earnings for use in the operation and expansion of our business. Issuer Purchases of Equity Securities On September 9, 2021, the Board authorized a securities repurchase program through September 27, 2022 of (i) up to 1,341,515 common shares and (ii) up to 411,962 Warrants in total, representing 10% of the 13,415,154 common shares and 10% of the 4,119,622 Warrants comprising the “public float” as of September 8, 2021. The program expired in September 2022. We expect to execute the securities repurchase program primarily in open market transactions on the TSX or Nasdaq, subject to market conditions. The Company most recently repurchased its common shares in January 2022 and did not repurchase any common shares during its fourth fiscal quarter. The following table contains information for the Warrants repurchased during the three months ended July 31, 2022. Month Total Number of Warrants Purchased Average Price Paid Per Warrant Total Number of Warrants Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Warrants that May Yet Be Purchased Under the Plans or Programs May 2022 14,821 $ 2.52 219,261 $ 485,607 June 2022 9,550 $ 2.65 228,881 485,165 July 2022 14,512 $ 2.66 243,323 438,461 Total 38,883 $ 2.60 243,323 $ 438,461 ITEM 6. Not applicable.